Document is current
Any future updates will be listed below
-
Authors
Detmer, Felicitas J.
Alpert, Nathaniel M.
Moon, Sung-Hyun
Dhaynaut, Maeva
Guerrero, J. Luis
Guehl, Nicolas J.
Xing, Fangxu
Brugarolas, Pedro
Shoup, Timothy M.
Normandin, Marc D.
Pelletier-Galarneau, Matthieu
El Fakhri, Georges
Petibon, Yoann
-
Funding
Funding for this research was provided by:
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
National Institutes of Health (P41EB022544)
- License Information
-
More Information
Article History
Received: 15 December 2021
Accepted: 8 March 2022
First Online: 12 April 2022
Competing interests
: Patent US 11,109,819 B2, ‘System and method for quantitatively mapping mitochondrial membrane potential’ (status: granted) is assigned to The General Hospital Corporation and lists Drs. Alpert, El Fakhri, Guehl and Normandin as inventors. The other authors declare that they have no potential conflict of interest.
